Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021 Jun 02, 2021 7:01am EDT
Kezar Appoints Rheumatology Industry Expert, Micki Klearman, MD, to its Board of Directors Jun 01, 2021 4:01pm EDT
Kezar Life Sciences to Participate in the Jefferies Virtual Healthcare Conference May 27, 2021 7:00am EDT
Kezar Life Sciences to Host Virtual MISSION Phase 1b Data Update Call at EULAR 2021 on June 2, 2021 May 26, 2021 4:01pm EDT
Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates May 12, 2021 4:01pm EDT
Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting Apr 10, 2021 8:30am EDT
Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates Mar 11, 2021 4:01pm EST
Kezar Life Sciences to Participate at Cowen 41st Annual Virtual Health Care Conference Feb 25, 2021 4:01pm EST
